Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2002 9
2003 6
2004 7
2005 3
2006 3
2007 4
2008 5
2009 10
2010 1
2011 4
2012 8
2013 5
2014 6
2015 10
2016 6
2017 3
2018 3
2019 6
2020 2
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
MTHFD2--a new twist?
Tedeschi PM, Scotto KW, Kerrigan J, Bertino JR. Tedeschi PM, et al. Among authors: bertino jr. Oncotarget. 2016 Feb 16;7(7):7368-9. doi: 10.18632/oncotarget.7147. Oncotarget. 2016. PMID: 26848977 Free PMC article. No abstract available.
In cancer, all roads lead to NADPH.
Rather GM, Pramono AA, Szekely Z, Bertino JR, Tedeschi PM. Rather GM, et al. Among authors: bertino jr. Pharmacol Ther. 2021 Oct;226:107864. doi: 10.1016/j.pharmthera.2021.107864. Epub 2021 Apr 22. Pharmacol Ther. 2021. PMID: 33894275 Review.
Exploiting methionine restriction for cancer treatment.
Chaturvedi S, Hoffman RM, Bertino JR. Chaturvedi S, et al. Among authors: bertino jr. Biochem Pharmacol. 2018 Aug;154:170-173. doi: 10.1016/j.bcp.2018.05.003. Epub 2018 May 4. Biochem Pharmacol. 2018. PMID: 29733806 Review.
Myeloprotection with drug-resistance genes.
Banerjee D, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Lancet Oncol. 2002 Mar;3(3):154-8. doi: 10.1016/s1470-2045(02)00678-2. Lancet Oncol. 2002. PMID: 11902501 Review.
NAD+ Kinase as a Therapeutic Target in Cancer.
Tedeschi PM, Bansal N, Kerrigan JE, Abali EE, Scotto KW, Bertino JR. Tedeschi PM, et al. Among authors: bertino jr. Clin Cancer Res. 2016 Nov 1;22(21):5189-5195. doi: 10.1158/1078-0432.CCR-16-1129. Epub 2016 Aug 31. Clin Cancer Res. 2016. PMID: 27582489 Review.
98 results